General Range
FORAXIME-50
Price on request/100 · MOQ 100 boxes
FORAXIME-50 Dry Syrup by Fortune Labs contains Cefixime, a third-generation cephalosporin antibiotic used to treat bacterial infections caused by susceptible microorganisms. Cefixime works by inhibiting bacterial cell wall synthesis, helping eliminate infection-causing bacteria. FORAXIME-50 may be prescribed for selected respiratory tract infections, throat infections, ear infections, urinary tract infections, and typhoid fever when clinically appropriate. Its pediatric oral suspension formulation provides a convenient administration option for children under medical supervision. Available in 30 ml dry syrup packaging, FORAXIME-50 is part of Fortune Labs' pediatric pharmaceutical portfolio. Fortune Labs offers Pediatric PCD Pharma Franchise and distribution opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use only as prescribed by a healthcare professional.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefixime 50 mg/5 ml
- Packaging Type
- Dry Syrup Bottle with Outer Carton
- Packaging Size
- 30 ml
- Dosage Form
- Oral Suspension
- Treatment
- Bacterial respiratory tract infections, throat infections, ear infections, urinary tract infections, typhoid fever, and other infections caused by sus
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
